AMENDED AND RESTATED MASTER SERVICE AGREEMENTProject Agreement • September 27th, 2019 • Theratechnologies Inc. • Pharmaceutical preparations • New Jersey
This Amended and Restated Master Service Agreement (this “Agreement”) is made as of December 14, 2016 (the “Effective Date”) by and between inVentiv Commercial Services, LLC with an office located at 500 Atrium Drive, Somerset, NJ 08873 (“inVentiv”) and Theratechnologies Inc., a Canadian corporation with offices located at 2015 Peel Street, 5th Floor, Montreal, Quebec, Canada H3A 1T8 (“Client”). Client and inVentiv may each be referred to herein as a “Party” and collectively, the “Parties”.
AMENDED AND RESTATED DISTRIBUTION AND MARKETING AGREEMENT DATED AS OF MARCH 6, 2017 BY AND BETWEEN THERATECHNOLOGIES INC. AND TAIMED BIOLOGICS INC.Distribution and Marketing Agreement • September 27th, 2019 • Theratechnologies Inc. • Pharmaceutical preparations • New York
THIS AMENDED AND RESTATED DISTRIBUTION AND MARKETING AGREEMENT (this “Agreement”) made as of March 6, 2017 (the “Execution Date”), by and between THERATECHNOLOGIES INC., a corporation organized under the laws of the Province of Québec, having its head office and principal place of business at 2015 Peel Street, 5th Floor, in the City of Montréal, Province of Québec, Canada, H3A 1T8 (“Theratechnologies”), and TaiMed Biologics Inc., a corporation organized under the laws of Taiwan, having its head office and principal place of business at 3F., No. 607, Ruiguang Rd., Neihu Dist., Taipei City 11492, Taiwan (“TaiMed”). Theratechnologies and TaiMed may hereinafter be referred to individually as a “Party” or collectively as the “Parties”.
AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENTAmended and Restated Exclusive License Agreement • September 27th, 2019 • Theratechnologies Inc. • Pharmaceutical preparations • Quebec
This amended and restated exclusive license agreement (this “Agreement”) is made and entered into this 25th day of February, 2019 (the “Effective Date”).
FIRST AMENDMENT TO AMENDED AND RESTATED MASTER SERVICE AGREEMENTMaster Service Agreement • September 27th, 2019 • Theratechnologies Inc. • Pharmaceutical preparations • Quebec
This First Amendment (the “Amendment”) dated February 27, 2019 (the “Effective Date”) is made by and between inVentiv Commercial Services, LLC, a Syneos HealthTM group company, with an office at 500 Atrium Drive, Somerset, N.J. 08873 (“Syneos Health”) and Theratechnologies Inc., a Canadian corporation with an office located at 2015 Peel Street, 5th Floor, Montreal, Quebec, Canada H3A IT8 (as the “Client”). Syneos Health and Client may each be referred to herein as a “Party” and, collectively, as the “Parties.”
AMENDED & RESTATED MASTER SERVICES AGREEMENTMaster Services Agreement • September 27th, 2019 • Theratechnologies Inc. • Pharmaceutical preparations • New York
This Amended and Restated Master Services Agreement (“Agreement”) is made as of the 1st day of November, 2017, by and between RxC Acquisition Company d/b/a RxCrossroads (“RxCrossroads”), a Delaware corporation with its principal place of business at 10350 Ormsby Park Place, Suite 500, Louisville, Kentucky 40223, and Theratechnologies Inc. (“Customer”), a corporation governed by the laws of Québec with a principal place of business at 2015 Peel Street., Suite 500, Montréal, Québec, H3A 1T8, Canada. RxCrossroads and Customer agree as follows:
TRUST INDENTURE between THERATECHNOLOGIES INC. - and - COMPUTERSHARE TRUST COMPANY OF CANADA Providing for the Issue of 5.75% Convertible Unsecured Senior Notes Dated as of June 19, 2018Trust Indenture • September 27th, 2019 • Theratechnologies Inc. • Pharmaceutical preparations
WHEREAS the Corporation, under the laws relating to it, is duly authorized to create and issue the Notes as herein provided;
AMENDMENT #1 TO SHARE PURCHASE AGREEMENT AMONG: TRANSFERT PLUS, L.P. AND ALIGO INNOVATION, L.P. AND BORHANE ANNABI AND RICHARD BÉLIVEAU AND CYNDIA CHARFI AND JEAN-CHRISTOPHE CURRIE AND ALAIN LAROCQUE AND MICHEL DEMEULE AND SOPHIE KOZELKO AND...Share Purchase Agreement • September 27th, 2019 • Theratechnologies Inc. • Pharmaceutical preparations
WHEREAS the Purchaser and the Vendors have entered into a share purchase agreement dated February 25, 2019 (the “Share Purchase Agreement”) pursuant to which Purchaser purchased all of the issued and outstanding common shares of Katana Biopharma Inc. (“Katana”);
SHARE PURCHASE AGREEMENT AMONG: TRANSFERT PLUS, L.P. AND ALIGO INNOVATION, L.P. AND BORHANE ANNABI AND RICHARD BÉLIVEAU AND CYNDIA CHARFI AND JEAN-CHRISTOPHE CURRIE AND ALAIN LAROCQUE AND MICHEL DEMEULE AND SOPHIE KOZELKO AND THERATECHNOLOGIES INC....Share Purchase Agreement • September 27th, 2019 • Theratechnologies Inc. • Pharmaceutical preparations • Quebec
WHEREAS the Corporation carries on the business of researching and developing peptides and peptide-drug conjugates for the treatment of cancer through receptor-mediated chemotherapy (the “Business”);
AMENDMENT#1Distribution and Marketing Agreement • September 27th, 2019 • Theratechnologies Inc. • Pharmaceutical preparations
This AMENDMENT #1 TO AMENDED AND RESTATED DISTRIBUTION AND MARKETING AGREEMENT (the “Amendment”), effective as of November 6, 2018 (the “Amendment Effective Date”), is made by and between TAIMED BIOLOGICS INC., a Taiwan corporation with the registered company address at 3F, No. 607, Ruiguang Road, Neihu District, Taipei City 11492, Taiwan, R.O.C. (“TaiMed”), and THERATECHNOLOGIES INC., a Canadian corporation organized under the laws of the Province of Quebec having its head office and principal place of business located at 2015 Peel Street, 5th floor, in the City of Montreal, Province of Quebec, Canada H3A 1T8 (“Theratechnologies”).
AMENDED AND RESTATED SHAREHOLDER RIGHTS PLAN AGREEMENTShareholder Rights Plan Agreement • September 27th, 2019 • Theratechnologies Inc. • Pharmaceutical preparations
AMENDED AND RESTATED SHAREHOLDER RIGHTS PLAN AGREEMENT made as of the 10th day of April, 2019 (amending and restating a shareholder rights plan agreement dated as of April 15, 2016).
